RXQ Compounding

company

About

RXQ Compounding, LLC is an FDA Approved 503B Outsourcing Facility .

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$7M
Industries
Health Care,Pharmaceutical
Founded date
Jan 1, 2014
Number Of Employee
11 - 50
Operating Status
Active

RXQ Compounding, LLC is an FDA Approved 503B Outsourcing Facility, currently located within the Ohio University Innovation Center in Athens, Ohio. They have partnered with the Ohio University Innovation Center to develop a viable enterprise here in Southern Ohio. RXQ Compounding, LLC is poised to be a leader in the new paradigm of manufacturing facilities across the country. Their team designed and implemented a stringent procedural manual that is now copyrighted. Other 503B Outsourcing Facilities that follow into this new realm will be hard pressed to find a more complete adaptation of the new regulations. RXQ Compounding, LLC emerged in front of new regulations from the FDA governing compounding facilities and the state board of pharmacy to assure that the safest products are delivered to our customers and patients.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$10.60M
RXQ Compounding has raised a total of $10.60M in funding over 2 rounds. Their latest funding was raised on Nov 24, 2020 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 24, 2020 Series A 1 Detail
Nov 8, 2019 Series A 1 Detail
Aug 23, 2018 Series Unknown $3.60M 1 Advantage Capital Detail
Jul 23, 2018 Series A $7M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
1
RXQ Compounding is funded by 1 investors. Advantage Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Advantage Capital Series A